Navigation Links
Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
Date:12/6/2007

mportant factors that could cause Rigel's results to differ materially from those indicated by these forward-looking statements, including risks associated with Rigel's drug discovery and development efforts, potential problems that may arise in clinical testing, as well as other risks detailed from time to time in Rigel's SEC reports, including its Form 10-Q for the quarter ended September 30, 2007. Rigel expressly disclaims any obligation or undertaking to update or revise any forward-looking statements made herein.

Contact: Raul Rodriguez

Phone: 650.624.1302

Email: invrel@rigel.com

Media Contact: Susan C. Rogers, Alchemy Consulting, Inc.

Phone: 650.430.3777

Email: susan@alchemyemail.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 LifeScienceIndustryResearch.com ... Azithromycin Industry and 2015 Deep Research Report ... to Pharmaceutical category in its database.  ... Azithromycin basic information, including definition, classification, application, ... and news analysis, etc. Azithromycin Key Manufacturers ...
(Date:4/1/2015)... , April 1, 2015 In what is ... and NAMSA -the leading global medical research organization -- are co-organizing ... will be held April 19-20 during the MEDTEC China South ... of the event is to assist Chinese medical device manufacturers ... that NAMSA will convene this conference in China ...
(Date:4/1/2015)... -- Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the ... chairman and executive director purchased 40,000,000 ordinary shares (the ... entire issued share capital of the Company from AMG ... amount of approximately HK$113 million. Upon the completion of ... 45.17% to 47.17%. Mr. Jin Dongtao, ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5MEDTEC & NAMSA Co-organize BPMDS Symposium China 2MEDTEC & NAMSA Co-organize BPMDS Symposium China 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5
... , , MINNEAPOLIS, Jan. 11 ATS Medical, Inc. ... surgery products and services today announced preliminary fourth quarter 2009 ... by ATS Medical,s President and Chief Executive Officer, Michael Dale, ... January 13, 2010, in San Francisco, CA, at 8 a.m. ...
... , , PRINCETON, N.J., Jan. 11 PharmaNet Development ... to innovative pharmaceutical, biotechnology, generic drug and medical device ... a complementary symposium and round table discussion entitled "Crossing ... , Recently, the Company successfully hosted a similar symposium ...
Cached Medicine Technology:ATS Medical Announces Preliminary Fourth Quarter 2009 Results 2ATS Medical Announces Preliminary Fourth Quarter 2009 Results 3ATS Medical Announces Preliminary Fourth Quarter 2009 Results 4PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to Clinical Studies' to be Held February 2010 in Basel, Dusseldorf and Vienna 2PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to Clinical Studies' to be Held February 2010 in Basel, Dusseldorf and Vienna 3
(Date:4/1/2015)... York (PRWEB) April 01, 2015 The ... of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled ... calendar for the Philadelphia Court of Common Pleas, the ... 206, City Hall. Court records indicate that the proceeding ... on behalf of Risperdal users who experienced gynecomastia (male ...
(Date:4/1/2015)... It all began at home in the kitchen of Shoosha ... mission to create a line of skincare for moms and ... Now, Shoosha Truly Organic is the only complete line of ... contain a minimum 95% certified organic ingredients, for babies and ... be 40% thinner than adults and of course much more ...
(Date:4/1/2015)... Altamonte Springs, FL (PRWEB) April 01, 2015 ... the nation’s leading innovative specialty pharmacies, has released a ... the latest treatment guidelines for treating chronic hepatitis C ... up-to-date treatment guidelines based on information from the American ... other credible, scientific sources. , Numerous new direct-acting oral ...
(Date:4/1/2015)... Northfield, IL, Bethesda, MD, Alexandria, VA (PRWEB) April ... for Clinical Pathology (ASCP), the College of American ... and the American Society of Clinical Oncology (ASCO) ... guideline on the use of molecular marker testing ... This evidence-based guideline will help establish standard molecular ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 EAGAN, Minn. ... Minnesota and its family of companies (Blue Cross) today ... out the year with net income of $61.5 million, ... losses. The organization reported a net operating loss of ... a negative operating margin of one-tenth of one percent ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3
... to lose weight might consider heading to the cardio ... out this month. // ,Both those who ... of weight, according to findings from an NIH-funded study ... while exercisers maintained their strength and muscle mass and ...
... produced a vaccine that activates the immune systems in ... ,During a clinical trial of 67 patients, researchers ... vaccines were injected pre and post surgery of the ... nearly 70 percent of patients. The November 15 issue ...
... drinks works as well as some sports drinks like Gatorade. ... and conducted by Indiana University // suggested found that ... 50% longer than those drinking a carbohydrate drink, an effect ... ,The story was picked up as mainstream news in ...
... memory during and after menopause, a change thought to be ... during that time. // ,Now, research from the ... help women retain certain memory functions. In a study in ... Metabolism, they report that a group of postmenopausal women showed ...
... hearing damage from acoustic shock, say health experts. // , ... functioning of the ear or of the nervous system, which ... earphone by a sudden sharp rise in the acoustic pressure ... a bleep or any unexpected noise. Two thirds of call ...
... identified by scientists from the Wistar Institute in Philadelphia and ... repression of the p53 protein // which is the most ... ,The new molecular pathway described in the study suggests ... many types of cancer. A report on the team's findings ...
Cached Medicine News:Health News:New Study Weighs Benefits of Exercise, Diets 2Health News:A novel vaccine proves a shot in the arm for colorectal cancer patients 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2Health News:Regulatory Mechanism for Tumor Suppressor Protein Identified 2Health News:Regulatory Mechanism for Tumor Suppressor Protein Identified 3
... The PK Plasma-CISE™ (wire ... are single use devices that ... with minimal thermal spread and ... for superior hemostasis. The devices ...
... Oncura's SeedNet system is a minimally invasive ... to learn and simple to use, SeedNet ... the cryoablation process. SeedNet is the ... Ultra-thin needles, exclusive to the SeedNet system, ...
Sterile Disposable Thermal Cautery Tips for Vasectomy. Individually peel-pouched with dual plastic sheaths to cover non-sterile handle. Box of 10 tips....
... The 2200 is ideal for applications ... of heat. , ,The autoclavable handpiece with ... thermal cautery electrodes, allowing the physician to ... variety of procedures., ,The 2200 includes the ...
Medicine Products: